US37611X1000 - Common Stock
GINKGO BIOWORKS HOLDINGS INC
NYSE:DNA (5/17/2024, 7:04:00 PM)
After market: 0.8149 +0.01 (+1.15%)0.8056
-0.03 (-3.98%)
Ginkgo Bioworks Holdings, Inc. is a biotech company. The company is headquartered in Boston, Massachusetts and currently employs 1,292 full-time employees. The company went IPO on 2021-04-19. Its cell programs are designed to enable biological production of products as diverse as therapeutics, key food ingredients and chemicals derived from petroleum. Its Foundry segment consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two assets: the Foundry, biology lab facilities, enabled by investment in workflows, custom software, robotic automation, and data science and analytics. Its Biosecurity segment consists of COVID-19 testing products and services primarily provided to public health authorities. The company also owns the adeno-associated virus capsid discovery and engineering platform assets.
GINKGO BIOWORKS HOLDINGS INC
27 Drydock Avenue, 8th Floor
Boston MASSACHUSETTS
P: 18774425362
CEO: Harry E. Sloan
Employees: 1292
Can this struggling stock turn things around?
These four small-cap stocks scan as deeply undervalued right now.
A few enterprising businesses are marketing themselves differently.
Here you can normally see the latest stock twits on DNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: